- Home
- BWA vs RVMD Comparison
BWA vs RVMD Comparison
Compare BWA & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWA
- RVMD
- Stock Information
- Founded
- BWA 1987
- RVMD 2014
- Country
- BWA United States
- RVMD United States
- Employees
- BWA N/A
- RVMD N/A
- Industry
- BWA Auto Parts:O.E.M.
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWA Consumer Discretionary
- RVMD Health Care
- Exchange
- BWA Nasdaq
- RVMD Nasdaq
- Market Cap
- BWA 6.3B
- RVMD 7.5B
- IPO Year
- BWA 1993
- RVMD 2020
- Fundamental
- Price
- BWA $44.02
- RVMD $40.50
- Analyst Decision
- BWA Buy
- RVMD Strong Buy
- Analyst Count
- BWA 14
- RVMD 14
- Target Price
- BWA $41.54
- RVMD $71.93
- AVG Volume (30 Days)
- BWA 2.4M
- RVMD 2.0M
- Earning Date
- BWA 10-30-2025
- RVMD 11-05-2025
- Dividend Yield
- BWA 1.54%
- RVMD N/A
- EPS Growth
- BWA N/A
- RVMD N/A
- EPS
- BWA 0.95
- RVMD N/A
- Revenue
- BWA $14,041,000,000.00
- RVMD N/A
- Revenue This Year
- BWA $1.92
- RVMD N/A
- Revenue Next Year
- BWA $2.95
- RVMD $387.56
- P/E Ratio
- BWA $44.14
- RVMD N/A
- Revenue Growth
- BWA N/A
- RVMD N/A
- 52 Week Low
- BWA $24.40
- RVMD $29.17
- 52 Week High
- BWA $44.32
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- BWA 76.20
- RVMD 65.02
- Support Level
- BWA $42.06
- RVMD $38.49
- Resistance Level
- BWA $43.83
- RVMD $40.98
- Average True Range (ATR)
- BWA 0.73
- RVMD 1.53
- MACD
- BWA -0.09
- RVMD 0.45
- Stochastic Oscillator
- BWA 89.98
- RVMD 89.28
About BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.